Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 81 - 90 of 250 items for :

  • paraganglioma x
  • Refine by access: All content x
Clear All
Alberto Cascón Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Alberto Cascón in
Google Scholar
PubMed Close
,
Lucía Inglada-Pérez Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Lucía Inglada-Pérez in
Google Scholar
PubMed Close
,
Iñaki Comino-Méndez Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Iñaki Comino-Méndez in
Google Scholar
PubMed Close
,
Aguirre A de Cubas Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Aguirre A de Cubas in
Google Scholar
PubMed Close
,
Rocío Letón Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Rocío Letón in
Google Scholar
PubMed Close
,
Jaume Mora Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Jaume Mora in
Google Scholar
PubMed Close
,
Mónica Marazuela Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Mónica Marazuela in
Google Scholar
PubMed Close
,
Juan Carlos Galofré Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Juan Carlos Galofré in
Google Scholar
PubMed Close
,
Miguel Quesada-Charneco Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Miguel Quesada-Charneco in
Google Scholar
PubMed Close
, and
Mercedes Robledo Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed Close

Dear Editor: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors that arise from the adrenal medulla or from the extra-adrenal sympathetic and parasympathetic paraganglia respectively. Now we know that more than 30% of

Article Type:
Journal Article
DOI:
https://doi.org/10.1530/ERC-12-0339
Volume/Issue:
Volume 20: Issue 3
Free access
Gergely Huszty Department of Surgery, Transplantation and Gastroenterology, Faculty of Medicine, Semmelweis University, Budapest, Hungary

Search for other papers by Gergely Huszty in
Google Scholar
PubMed Close
and
Peter Igaz Department of Endocrinology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary

Search for other papers by Peter Igaz in
Google Scholar
PubMed Close

Dear Editor, We have read the recent article of Zhang et al. , published in the July 2023 issue of Endocrine-Related Cancer article ID e220354 , on the risk of complications after core needle biopsy of pheochromocytoma/paraganglioma

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-23-0220
Volume/Issue:
Volume 31: Issue 1
Restricted access
Raquel G Martins IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Raquel G Martins in
Google Scholar
PubMed Close
,
Joana B Nunes IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Joana B Nunes in
Google Scholar
PubMed Close
,
Valdemar Máximo IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Valdemar Máximo in
Google Scholar
PubMed Close
,
Paula Soares IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Paula Soares in
Google Scholar
PubMed Close
,
Joana Peixoto IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Joana Peixoto in
Google Scholar
PubMed Close
,
Telmo Catarino IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Telmo Catarino in
Google Scholar
PubMed Close
,
Teresa Rito IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Teresa Rito in
Google Scholar
PubMed Close
,
Pedro Soares IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Pedro Soares in
Google Scholar
PubMed Close
,
Luísa Pereira IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Luísa Pereira in
Google Scholar
PubMed Close
,
Manuel Sobrinho-Simões IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed Close
,
Ana Paula Santos IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Ana Paula Santos in
Google Scholar
PubMed Close
,
Joana Couto IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Joana Couto in
Google Scholar
PubMed Close
,
Rui Henrique IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Rui Henrique in
Google Scholar
PubMed Close
,
Joana Matos-Loureiro IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Joana Matos-Loureiro in
Google Scholar
PubMed Close
,
Paula Dias IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Paula Dias in
Google Scholar
PubMed Close
,
Isabel Torres IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Isabel Torres in
Google Scholar
PubMed Close
, and
Jorge Lima IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal

Search for other papers by Jorge Lima in
Google Scholar
PubMed Close

Dear Editor We would like to report a genetic screening of SDHB , SDHC , SDHD and SDHAF2 genes (hereafter abbreviated to SDHx ) in patients with paragangliomas (PGL) and phaeochromocytomas (PCC) from northern Portugal. PGL and PCC are

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-12-0399
Volume/Issue:
Volume 20: Issue 6
Free access
Elizabeth Grubbs Departments of Surgical Oncology, GI Medical Oncology, and Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas

Search for other papers by Elizabeth Grubbs in
Google Scholar
PubMed Close
,
Daniel Halperin Departments of Surgical Oncology, GI Medical Oncology, and Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas

Search for other papers by Daniel Halperin in
Google Scholar
PubMed Close
,
Steven G Waguespack Departments of Surgical Oncology, GI Medical Oncology, and Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas

Search for other papers by Steven G Waguespack in
Google Scholar
PubMed Close
, and
Robert F Gagel Departments of Surgical Oncology, GI Medical Oncology, and Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas

Search for other papers by Robert F Gagel in
Google Scholar
PubMed Close

Overview The multiple endocrine neoplasia syndromes are a varied group of disorders that include multiple endocrine neoplasia types 1 and 2 (MEN 1, MEN 2), von Hippel-Lindau (VHL) disease , Carney complex (CC), hereditary pheochromocytoma/paraganglioma

Article Type:
Editorial
DOI:
https://doi.org/10.1530/ERC-20-0201
Volume/Issue:
Volume 27: Issue 8
Free access
Judith Favier Université Paris Cité, Inserm UMR970 PARCC, Equipe Labellisée par la Ligue contre le cancer, Paris, France

Search for other papers by Judith Favier in
Google Scholar
PubMed Close
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close
, and
Roderick Clifton-Bligh Department of Endocrinology Royal North Shore Hospital, University of Sydney, Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close

The endocrine community has witnessed significant advances in the understanding and management of pheochromocytoma and paraganglioma, thanks to the continuous and unprecedented efforts of healthcare professionals and researchers worldwide. The 6th

Article Type:
Editorial
DOI:
https://doi.org/10.1530/ERC-24-0050
Volume/Issue:
Volume 31: Issue 8
Restricted access
Ruth T Casey Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK
Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed Close
,
Benjamin G Challis Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Benjamin G Challis in
Google Scholar
PubMed Close
,
Alison Marker Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Alison Marker in
Google Scholar
PubMed Close
,
Deborah Pitfield Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Deborah Pitfield in
Google Scholar
PubMed Close
,
Heok K Cheow Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Search for other papers by Heok K Cheow in
Google Scholar
PubMed Close
,
Ashley Shaw Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Search for other papers by Ashley Shaw in
Google Scholar
PubMed Close
,
Soo-Mi Park Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK

Search for other papers by Soo-Mi Park in
Google Scholar
PubMed Close
,
Helen L Simpson Department of Diabetes and Endocrinology, University College London Hospitals, NHS Foundation Trust, London, UK

Search for other papers by Helen L Simpson in
Google Scholar
PubMed Close
, and
Eamonn R Maher Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK

Search for other papers by Eamonn R Maher in
Google Scholar
PubMed Close

Dear Editor, We have read with great interest the recent article by Tufton and coworkers reporting on the risk of metastasis in patients with paraganglioma (PGL) tumours associated with germline SDHA mutations ( Tufton et al . 2017 ). Herein

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-17-0206
Volume/Issue:
Volume 24: Issue 8
Open access
Hartmut P H Neumann Unit for Preventive Medicine, Department of Internal Medicine, University Medical Center, Albert‐Ludwigs‐University, Hugstetter Straße 55, D‐79106 Freiburg, Germany

Search for other papers by Hartmut P H Neumann in
Google Scholar
PubMed Close
and
Wouter de Herder Unit for Preventive Medicine, Department of Internal Medicine, University Medical Center, Albert‐Ludwigs‐University, Hugstetter Straße 55, D‐79106 Freiburg, Germany

Search for other papers by Wouter de Herder in
Google Scholar
PubMed Close

puzzling Dutch paraganglioma family. He and his collaborators mapped the susceptibility gene locus to 11q23 and linked it to a gene encoding one of the four subunits of succinate dehydrogenase (mitochondrial complex II, SDHD), an enzyme that lies at the all

Article Type:
Editorial
DOI:
https://doi.org/10.1530/ERC-15-0340
Volume/Issue:
Volume 22: Issue 4
Free access
Thibault Bahougne Service d’Endocrinologie et Diabétologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Institut des Neurosciences Cellulaires et Intégratives, CNRS (UPR 3212), Strasbourg, France

Search for other papers by Thibault Bahougne in
Google Scholar
PubMed Close
,
Alessio Imperiale Service de Biophysique et de Médecine Nucléaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
ICube, UMR 7357 Université de Strasbourg/CNRS et FMTS, Faculté de Medécine, Strasbourg, France

Search for other papers by Alessio Imperiale in
Google Scholar
PubMed Close
,
Gerlinde Averous Département de Pathologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for other papers by Gerlinde Averous in
Google Scholar
PubMed Close
,
Gerard Chabrier Service d’Endocrinologie et Diabétologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for other papers by Gerard Chabrier in
Google Scholar
PubMed Close
,
Nelly Burnichon Département de Génétique, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Université Paris Descartes, PRES Sorbonne Paris Cité, Faculté de Médecine, Paris, France
INSERM, UMR970, Paris-Centre de Recherche Cardiovasculaire, Paris, France

Search for other papers by Nelly Burnichon in
Google Scholar
PubMed Close
,
Anne Paule Gimenez-Roqueplo Département de Génétique, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Université Paris Descartes, PRES Sorbonne Paris Cité, Faculté de Médecine, Paris, France
INSERM, UMR970, Paris-Centre de Recherche Cardiovasculaire, Paris, France
Centre Expert National COMETE-Cancer de la surrénale, Paris, France

Search for other papers by Anne Paule Gimenez-Roqueplo in
Google Scholar
PubMed Close
,
Nassim Dali-Youcef Laboratoire de Biochimie et de Biologie Moléculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC)/CNRS/INSERM/Université de Strasbourg, Illkirch, France

Search for other papers by Nassim Dali-Youcef in
Google Scholar
PubMed Close
,
Rossella Libe Centre Expert National COMETE-Cancer de la surrénale, Paris, France
Endocrinology Department, Cochin Hospital, Paris, France
Département de Médecine Nucléaire et de Tumeurs Endocrines, Institut Gustave Roussy, Université Paris Sud, Villejuif, France

Search for other papers by Rossella Libe in
Google Scholar
PubMed Close
,
Eric Baudin Département de Médecine Nucléaire et de Tumeurs Endocrines, Institut Gustave Roussy, Université Paris Sud, Villejuif, France

Search for other papers by Eric Baudin in
Google Scholar
PubMed Close
,
Catherine Roy Service de Radiologie B, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for other papers by Catherine Roy in
Google Scholar
PubMed Close
,
Herve Lang Service d’Urologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for other papers by Herve Lang in
Google Scholar
PubMed Close
, and
Laurence Kessler Service d’Endocrinologie et Diabétologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for other papers by Laurence Kessler in
Google Scholar
PubMed Close

Dear Editor, Pheochromocytoma (PHEO) and extra-adrenal paraganglioma (PGL) are neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and the autonomic nervous system, respectively. These neoplasms are malignant in

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-16-0431
Volume/Issue:
Volume 24: Issue 2
Free access
David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed Close
,
Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed Close
,
Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

Nuclear medicine as a component of precision medicine This article is a summary of a plenary lecture presented at the 6th International Symposium on Pheochromocytoma/Paraganglioma (20 October 2022, Prague, Czech Republic), which explored the

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0375
Volume/Issue:
Volume 30: Issue 4
Free access
Zhengping Zhuang Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Zhengping Zhuang in
Google Scholar
PubMed Close
,
Chunzhang Yang Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Chunzhang Yang in
Google Scholar
PubMed Close
,
Ales Ryska The Fingerland Department of Pathology, Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic

Search for other papers by Ales Ryska in
Google Scholar
PubMed Close
,
Yuan Ji Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yuan Ji in
Google Scholar
PubMed Close
,
Yingyong Hou Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yingyong Hou in
Google Scholar
PubMed Close
,
Sky D Graybill San Antonio Military Medical Center, Fort Sam Houston, Texas, USA

Search for other papers by Sky D Graybill in
Google Scholar
PubMed Close
,
Petra Bullova Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA
Department of Molecular Medicine, Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovakia

Search for other papers by Petra Bullova in
Google Scholar
PubMed Close
,
Irina A Lubensky Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Irina A Lubensky in
Google Scholar
PubMed Close
,
Günter Klöppel Consultation Center for Pancreas and Neuroendocrine Tumors, Department of Pathology, Technical University Munich, Munich, Germany

Search for other papers by Günter Klöppel in
Google Scholar
PubMed Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

Dear Editor, Somatic hypoxia-inducible factor 2 alpha ( HIF2A ) mutations are responsible for a newly discovered syndrome of multiple paragangliomas (PGL) and duodenal somatostatinomas associated with polycythemia (Pacak–Zhuang syndrome

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-16-0148
Volume/Issue:
Volume 23: Issue 5
Free access